These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35253141)
1. Managing Uncertainty: Physicians' Decision Making for Stroke Prevention for Patients with Atrial Fibrillation and Intracerebral Hemorrhage. Ivany E; Lotto RR; Lip GYH; Lane DA Thromb Haemost; 2022 Sep; 122(9):1603-1611. PubMed ID: 35253141 [TBL] [Abstract][Full Text] [Related]
2. Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study. Pokorney SD; Bloom D; Granger CB; Thomas KL; Al-Khatib SM; Roettig ML; Anderson J; Heflin MT; Granger BB Eur J Cardiovasc Nurs; 2019 Apr; 18(4):280-288. PubMed ID: 30418049 [TBL] [Abstract][Full Text] [Related]
3. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation. Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360 [TBL] [Abstract][Full Text] [Related]
4. Family Physician Prescribing Practices and Perspectives on Shared Decision-Making Regarding the Use of Oral Anticoagulants for Stroke Prevention in Patients 75 Years or Older With Atrial Fibrillation. Ali J; Abbasi-Dezfouly R; Khera S; Kivi P; Tian PGJ J Prim Care Community Health; 2023; 14():21501319231164060. PubMed ID: 36960556 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Decisions in Atrial Fibrillation for Stroke Prevention: The Role of Aversion to Ambiguity and Physicians' Risk Preferences. Sposato LA; Stirling D; Saposnik G J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2088-2095. PubMed ID: 29650382 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey. Ivany E; Lane DA; Dan GA; Doehner W; Farkowski MM; Iliodromitis K; Lenarczyk R; Potpara TS Europace; 2021 May; 23(5):806-814. PubMed ID: 34020460 [TBL] [Abstract][Full Text] [Related]
7. Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage. Stanton RJ; Eckman MH; Woo D; Moomaw CJ; Haverbusch M; Flaherty ML; Kleindorfer DO Stroke; 2020 Mar; 51(3):808-814. PubMed ID: 32000590 [TBL] [Abstract][Full Text] [Related]
8. Informed Decision Making for Anticoagulation Therapy for Atrial Fibrillation. Martinez KA; Linfield DT; Shaker V; Rothberg MB Med Decis Making; 2023 Feb; 43(2):263-269. PubMed ID: 36059267 [TBL] [Abstract][Full Text] [Related]
9. 'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation. Anderson N; Fuller R; Dudley N QJM; 2007 May; 100(5):263-9. PubMed ID: 17389657 [TBL] [Abstract][Full Text] [Related]
11. Aversion to ambiguity and willingness to take risks affect therapeutic decisions in managing atrial fibrillation for stroke prevention: results of a pilot study in family physicians. Raptis S; Chen JN; Saposnik F; Pelyavskyy R; Liuni A; Saposnik G Patient Prefer Adherence; 2017; 11():1533-1539. PubMed ID: 28979101 [TBL] [Abstract][Full Text] [Related]
12. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729 [TBL] [Abstract][Full Text] [Related]
14. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ? Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing primary care physicians' prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study. Chaterji S; Lian LG; Lee TY; Chua L; Wee SY; Yap SL; K DL; Tan NC BMC Fam Pract; 2021 May; 22(1):101. PubMed ID: 34034648 [TBL] [Abstract][Full Text] [Related]
16. Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review. Mas Dalmau G; Sant Arderiu E; Enfedaque Montes MB; Solà I; Pequeño Saco S; Alonso Coello P BMC Fam Pract; 2017 Jan; 18(1):3. PubMed ID: 28086887 [TBL] [Abstract][Full Text] [Related]
17. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study. Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992 [TBL] [Abstract][Full Text] [Related]
18. Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making. Eckman MH; Wise RE; Naylor K; Arduser L; Lip GY; Kissela B; Flaherty M; Kleindorfer D; Khan F; Schauer DP; Kues J; Costea A Curr Med Res Opin; 2015 Apr; 31(4):603-14. PubMed ID: 25690491 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis. Abrantes CS; Pintalhão M; Tavares S; Fonseca L; Chaves PC Neurol Sci; 2022 Apr; 43(4):2441-2448. PubMed ID: 34542785 [TBL] [Abstract][Full Text] [Related]